PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Overview Fund Activity
Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

25 hedge funds and large institutions have $464M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 79 closing their positions.

Holders
25
Holders Change
-60
Holders Change %
-70.59%
% of All Funds
0.39%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.08%
New
20
Increased
4
Reduced
1
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Temasek Holdings
1
Temasek Holdings
Singapore
$166M
2
5VM
2
5AM Venture Management
California
$116M
3
SGA
3
SB Global Advisers
United Kingdom
$75M
4
TAA
4
TB Alternative Assets
Cayman Islands
$12.8M
5
PA
5
Perceptive Advisors
New York
$5.74M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
CM
2
Cohanzick Management
New York
$0
3
RA
3
RiverPark Advisors
New York
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
AC
5
Aristeia Capital
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EIP
101
Easterly Investment Partners
Massachusetts
– -$99K -10,000 Closed
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
– -$56K -5,667 Closed
FIA
103
FNY Investment Advisers
New York
– -$1K -200 Closed
1 2 3 4
5